Heart Disease Is a Women’s Health Issue — Starting at Menopause
Here’s a statistic that surprises many women: heart disease is the number one cause of death in women in the United States, killing more women than all cancers combined. And the menopause transition is when women’s cardiovascular risk begins its most significant acceleration. Before menopause, women enjoy a lower rate of heart disease than men the same age. After menopause, that protective gap closes — and eventually, older women develop and die from heart disease at rates exceeding those of men their age.
At our gynecology practice in Sugar Land and Missouri City, we believe that comprehensive menopause care has to address cardiovascular health — not just symptoms. Understanding your risk and taking proactive steps during and after the menopause transition can meaningfully reduce your lifetime risk of heart attack, stroke, and heart failure.
How Estrogen Protects the Heart — and What Happens When It Declines
Estrogen has multiple favorable effects on the cardiovascular system. It promotes vasodilation (relaxing and widening blood vessels), reduces levels of LDL (‘bad’) cholesterol while increasing HDL (‘good’) cholesterol, has anti-inflammatory and antioxidant properties in blood vessel walls, supports healthy insulin sensitivity, and helps regulate blood pressure. When estrogen declines with menopause, all of these protective effects diminish.
The cardiovascular consequences of estrogen loss are measurable and clinically significant. After menopause, LDL cholesterol typically increases by 10 to 15 percent while HDL cholesterol often decreases. Triglycerides rise. Blood pressure increases. Inflammatory markers increase. Insulin resistance worsens, increasing the risk of type 2 diabetes. Abdominal fat accumulates, which is independently associated with cardiovascular disease. The arterial walls stiffen, and early markers of atherosclerosis (plaque buildup in artery walls) begin to appear.
Research shows that these changes can begin during perimenopause, not just after the final period. A 2024 publication in PMC documented that women in the perimenopause transition already show early indicators of hypertension, oxidative stress, and endothelial dysfunction — making the menopause transition a critical window for cardiovascular risk assessment and early intervention.
The Key Cardiovascular Risk Factors to Monitor
Every woman going through or past menopause should have regular monitoring of cardiovascular risk factors. Blood pressure is one of the most important. Hypertension (high blood pressure) becomes significantly more common after menopause — partly due to estrogen’s role in blood vessel regulation — and it’s a major, modifiable risk factor for heart attack and stroke. Blood pressure should be checked at every healthcare visit.
Cholesterol and lipid levels should be checked at least every five years in healthy adults, and more frequently in women with risk factors or those in the menopause transition. The pattern most common in postmenopausal women — elevated LDL, low HDL, elevated triglycerides — represents significant cardiovascular risk. Dietary changes, physical activity, and when needed, statin therapy, can meaningfully address this.
Blood glucose and HbA1c should be monitored for diabetes and pre-diabetes, which become substantially more common after menopause. The combination of insulin resistance (worsened by estrogen loss), weight gain, and reduced physical activity creates a high-risk metabolic environment in many postmenopausal women.
Body weight and waist circumference matter, particularly abdominal adiposity. Abdominal fat is metabolically active in ways that peripheral fat (in the thighs and hips) is not — it releases inflammatory mediators and free fatty acids that directly worsen cardiovascular risk. Weight gain around the middle, which accelerates during menopause, is worth taking seriously as a health concern, not just a cosmetic one.
Hot Flashes and Cardiovascular Risk
Emerging research suggests that the most bothersome menopause symptom — hot flashes — may itself be a cardiovascular risk marker. Multiple studies have found associations between frequent and severe vasomotor symptoms and higher rates of cardiovascular disease, arterial stiffness, adverse lipid changes, and other cardiovascular risk indicators. A 2024 pooled analysis published in the Journal of the American Heart Association found elevated cardiovascular disease risk in women with PCOS, and similar associations have been documented for frequent hot flashes.
The mechanism isn’t fully established, but may involve the same neurological and vascular changes that produce hot flashes also affecting cardiovascular function. Women with severe, frequent hot flashes — particularly those that begin before or early in the menopause transition — may warrant more proactive cardiovascular risk assessment.
The Role of Hormone Therapy in Cardiovascular Risk
This is one of the most nuanced areas of menopause medicine. The relationship between hormone therapy and cardiovascular health depends critically on timing — when therapy is started relative to menopause onset.
For recently menopausal women (under 60 or within 10 years of menopause), hormone therapy does not appear to increase cardiovascular risk and may be cardioprotective — reducing LDL cholesterol, decreasing arterial stiffness, and improving metabolic parameters. This is the ‘timing hypothesis’ supported by the KEEPS and ELITE studies. For women who start HT more than 10 years after menopause or over age 60 who have already established subclinical atherosclerosis, the risk-benefit ratio is different, and HT is generally not recommended as a cardiovascular preventive strategy.
Transdermal estrogen (patches, gels) has a more favorable cardiovascular safety profile than oral estrogen because it avoids first-pass liver effects that can raise triglycerides and clotting factors. For women with cardiovascular risk factors, transdermal delivery is preferred when HT is considered.
Lifestyle as Powerful Cardiovascular Medicine
The most consistently powerful tools for cardiovascular protection after menopause are lifestyle-based, and they work regardless of hormone therapy status. Regular physical activity is among the most potent interventions available. Aerobic exercise improves cholesterol profiles, reduces blood pressure, improves insulin sensitivity, reduces inflammation, and maintains healthy body weight. The American Heart Association recommends at least 150 minutes of moderate-intensity aerobic activity per week for cardiovascular health — a target that also aligns with menopause symptom management guidelines.
A heart-healthy diet pattern — rich in vegetables, fruits, whole grains, legumes, nuts, and fish while limiting saturated fat, trans fat, added sugars, and excess sodium — has robust evidence for reducing cardiovascular events. The Mediterranean diet pattern, which also has evidence in PCOS management, is equally well-supported for postmenopausal cardiovascular health.
Smoking cessation is critically important — smoking dramatically increases cardiovascular risk at every age and accelerates atherosclerosis. If you currently smoke, quitting is the single most impactful health decision you can make. Our practice can connect you with cessation support resources.
Screening and Follow-Up
Comprehensive cardiovascular screening should be part of your routine healthcare after menopause. Beyond blood pressure, cholesterol, and blood glucose, consider discussing coronary calcium scoring with your provider — a low-radiation CT scan that detects calcium deposits in the coronary arteries, providing an early, direct measure of atherosclerosis that helps guide treatment decisions.
Women in Sugar Land, Missouri City, and throughout Fort Bend County have excellent access to cardiovascular screening and care. Our gynecology practice coordinates closely with primary care and cardiology to ensure our patients’ cardiovascular health is monitored proactively throughout the menopause years and beyond.
